Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT) part 5: Diagnostic value of the eNose in Colorectal Cancer

Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT) part 5: Diagnostic value of the eNose in Colorectal Cancer - eNose in colorectal cancer/SCENT study, part 5

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON34063

Enrollment

Registered

2010-07-01

Start date

2010-08-10

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bowel cancer colorectal carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Written informed consent obtained. Colorectal cancer: • adult 18-80 years • histological proven CRC Controls: Matched for: • Age: =age= 3 months B. current smoker or ex-smoker

Exclusion criteria

Exclusion criteria: • periodontitis • any infection (especially of the airways) in the last 4 weeks • known pulmonary disease • Other or former malignancy • Diabetes mellitus (documented in the past) • Pregnancy • Untreated hypercholesterolaemia (documented in the past) • Significant cardiovascular disease (documented in the past) • Healthy controls: Any abnormal findings at colonoscopy (e.g. like polyps)

Design outcomes

Primary

Measure	Time frame
primary outcome parameter is the difference in breathprints provided by the electronic nose	—

Countries

Netherlands

Outcome results